Elena McBeath
Overview
Explore the profile of Elena McBeath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen M, Imanishi M, Li S, Chau K, Banerjee P, Velatooru L, et al.
Front Cardiovasc Med
. 2023 Sep;
10:1187490.
PMID: 37711550
Background: The deSUMOylase sentrin-specific isopeptidase 2 (SENP2) plays a crucial role in atheroprotection. However, the phosphorylation of SENP2 at T368 under disturbed flow (D-flow) conditions hinders its nuclear function and...
2.
McBeath E, Fujiwara K, Hofmann M
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373404
Up until recently, methods for generating floxed mice either conventionally or by CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9 (CRISPR-associated protein 9) editing have been technically challenging, expensive and error-prone,...
3.
Parker-Thornburg J, Benavides F, Shawlot W, McBeath E
Transgenic Res
. 2022 Nov;
31(6):677-681.
PMID: 36441390
No abstract available.
4.
Hofmann M, McBeath E
Front Endocrinol (Lausanne)
. 2022 Jun;
13:897062.
PMID: 35757413
Male germ cell development depends on multiple biological events that combine epigenetic reprogramming, cell cycle regulation, and cell migration in a spatio-temporal manner. Sertoli cells are a crucial component of...
5.
Bagheri-Yarmand R, Busaidy N, McBeath E, Danysh B, Evans K, Moss T, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638434
-activating mutations are the most frequent driver mutations in papillary thyroid cancer (PTC). Targeted inhibitors such as dabrafenib have been used in advanced -mutated PTC; however, acquired resistance to the...
6.
Kotla S, Zhang A, Imanishi M, Ko K, Lin S, Gi Y, et al.
Redox Biol
. 2021 Oct;
47:102132.
PMID: 34619528
The incidence of cardiovascular disease (CVD) is higher in cancer survivors than in the general population. Several cancer treatments are recognized as risk factors for CVD, but specific therapies are...
7.
McBeath E, Parker-Thornburg J, Fujii Y, Aryal N, Smith C, Hofmann M, et al.
Genes (Basel)
. 2020 Jun;
11(6).
PMID: 32521708
Although the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/ CRISPR associated protein 9 (Cas9) technique has dramatically lowered the cost and increased the speed of generating genetically engineered mice, success...
8.
Abe J, Ko K, Kotla S, Wang Y, Paez-Mayorga J, Shin I, et al.
JCI Insight
. 2019 Apr;
4(7).
PMID: 30944250
The possible association between the membrane-associated guanylate kinase with inverted domain structure-1 (MAGI1) and inflammation has been suggested, but the molecular mechanisms underlying this link, especially during atherogenesis, remain unclear....
9.
Singh M, Kotla S, Le N, Ko K, Heo K, Wang Y, et al.
Circulation
. 2018 Dec;
139(9):1199-1216.
PMID: 30586719
Background: The incidence of cardiovascular disease is higher in HIV-positive (HIV) patients than it is in the average population, and combination antiretroviral therapy (cART) is a recognized risk factor for...
10.
Puli O, Danysh B, McBeath E, Sinha D, Hoang N, Powell R, et al.
Neoplasia
. 2018 Sep;
20(11):1121-1134.
PMID: 30265861
The ETS family of transcription factors is involved in several normal remodeling events and pathological processes including tumor progression. ETS transcription factors are divided into subfamilies based on the sequence...